Showing results (221-230 of 401) with videos related to
Sort By:
Pageof 41
MMWR. Morbidity and Mortality Weekly Report|October 6, 2017
Retention in Medical Care Among Insured Children with Diagnosed HIV Infection - United States, 2010-2014Mary R Tanner, Tim Bush, Steven R Nesheim, et al.Biochemistry|June 3, 1999
Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B)M B Boffa, T S Reid, E Joo, et al.Science (New York, N.Y.)|January 24, 1997
An Fe2IVO2 diamond core structure for the key intermediate Q of methane monooxygenaseL Shu, J C Nesheim, K Kauffmann, et al.Journal of Crohn'S & Colitis|January 21, 2012
Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases TAFIa level in patients with IBDDanuta Owczarek, Anetta Undas, Jonathan H Foley, et al.The Journal of Biological Chemistry|June 30, 1995
The activation-resistant conformation of recombinant human plasminogen is stabilized by basic residues in the amino-terminal hinge regionA J Horrevoets, A E Smilde, J C Fredenburgh, et al.Public Health Reports (Washington, D.C. : 1974)|June 16, 2021
Retention in Medical Care Among Insured Adolescents and Young Adults With Diagnosed HIV Infection, United States, 2010-2014Mary R Tanner, Tim Bush, Steven R Nesheim, et al.Journal - Association of Official Analytical Chemists|January 1, 1986
Thin layer chromatographic method for determination of deoxynivalenol in wheat: collaborative studyR M Eppley, M W Trucksess, S Nesheim, et al.Journal of Comparative Effectiveness Research|November 10, 2022
Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature reviewCorinne Duperrouzel, Coby Martin, Ari Mendell, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2003
Quantitative RNA testing for diagnosis of HIV-infected infantsSteven Nesheim, Paul Palumbo, Kevin Sullivan, et al.Blood|February 1, 1982
The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbitsA R Giles, M E Nesheim, H Hoogendoorn, et al.Pageof 41